SY8 is useful for studies of changes in involucrin expression in pathological studies.
| Inventor | Institute |
|---|---|
| Fiona Watt | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151164 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction |
| Application: | IHC ; IF ; IP ; WB |
| Target: | Involucrin |
| Reactivity: | Dog ; Human ; Pig ; Primate |
| Clone: | SY8 |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | SY8 is useful for studies of changes in involucrin expression in pathological studies. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 66-170 kDa |
| Immunogen: | Purified involucrin from human keratinocytes. |
| Myeloma used: | P3X63Ag8 |
| Target background: | Involucrin is a protein precursor of the epidermal cornified envelope and a differentiation marker of human keratinocytes. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | '-15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Howie et al. 2011. PLoS Pathog. 7(8):e1002211. PMID: 21901101. Beta-HPV 5 and 8 E6 promote p300 degradation by blocking AKT/p300 association. Hudson et al. 1992. Hybridoma. 11(3):367-79. PMID: 1500072. Characterisation of eight monoclonal antibodies to involucrin. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151037 | Anti-Cdk1 [17 (A17)] |
Key Info
Anti-Cdk1 [17 (A17)]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.